8 results
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Clinical Disease ... duration same as for treatment ... Disease Note: Treatment ... clinical manifestation ... #Treatment #management
Chagas Disease (American trypanosomiasis) - Diagnosis and Management Summary
Acute Chagas Disease (8-12 weeks):
 • Mild: Malaise,
Diagnosis and Management ... Disease (8-12 weeks ... • Treatment: ... Disease": T. cruzi + clinical ... T.cruzi without clinical
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Clinical • Under-recognized ... • Account for changes ... months before 1° prevention ... teratogenic GDMT meds ... #cardiology #treatment
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Seizures • Vision changes ... territories signal changes ... epilepticus Treatment ... underlying cause • Treatment ... Syndrome #diagnosis #management
Chagas Disease (American trypanosomiasis) - Diagnosis and Management Summary
Acute Chagas Disease (8-12 weeks):
 • Mild: Malaise,
Diagnosis and Management ... Disease (8-12 weeks ... • Treatment: ... Disease": T. cruzi + clinical ... T.cruzi without clinical
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... weeks or until clinically ... BID for at least 12 ... Histoplasmosis #IDSA #Prevention ... #Treatment #management
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
prior history of treatment ... 50 mg weekly x 12 ... HIV-infected persons with clinical ... Tuberculosis #TB #IDSA #Prevention ... #Treatment #management
Thiopurines in IBD
Indications:
 • Steroid-sparing agents indicated for maintenance of remission in UC and CD
 •
onset of action (~12 ... and after dose changes ... associated to good clinical ... #BowelDisease #Management ... #Treatment